RU98107565A - Получение рекомбинантного фактора viii в среде, не содержащей белка - Google Patents
Получение рекомбинантного фактора viii в среде, не содержащей белкаInfo
- Publication number
- RU98107565A RU98107565A RU98107565/13A RU98107565A RU98107565A RU 98107565 A RU98107565 A RU 98107565A RU 98107565/13 A RU98107565/13 A RU 98107565/13A RU 98107565 A RU98107565 A RU 98107565A RU 98107565 A RU98107565 A RU 98107565A
- Authority
- RU
- Russia
- Prior art keywords
- medium
- ions
- factor viii
- amount varying
- cells
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title claims 4
- 108090000623 proteins and genes Proteins 0.000 title claims 4
- 239000002609 media Substances 0.000 claims 6
- 102000001690 Factor VIII Human genes 0.000 claims 4
- 108010054218 Factor VIII Proteins 0.000 claims 4
- 229960000301 Factor VIII Drugs 0.000 claims 4
- 210000004027 cells Anatomy 0.000 claims 4
- 229920005862 polyol Polymers 0.000 claims 3
- 150000003077 polyols Chemical class 0.000 claims 3
- 229910001431 copper ion Inorganic materials 0.000 claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
- 150000002500 ions Chemical class 0.000 claims 2
- 210000003292 kidney cell Anatomy 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims 2
- 229910052750 molybdenum Inorganic materials 0.000 claims 2
- 239000011733 molybdenum Substances 0.000 claims 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L Copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims 1
- 241000699800 Cricetinae Species 0.000 claims 1
- 241000699802 Cricetulus griseus Species 0.000 claims 1
- 102000004877 Insulin Human genes 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- 210000001672 Ovary Anatomy 0.000 claims 1
- 239000007640 basal medium Substances 0.000 claims 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims 1
- 229910052804 chromium Inorganic materials 0.000 claims 1
- 239000011651 chromium Substances 0.000 claims 1
- 229910001430 chromium ion Inorganic materials 0.000 claims 1
- 229910000365 copper sulfate Inorganic materials 0.000 claims 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims 1
- 229910052744 lithium Inorganic materials 0.000 claims 1
- 229910001416 lithium ion Inorganic materials 0.000 claims 1
- 210000004962 mammalian cells Anatomy 0.000 claims 1
- PWHULOQIROXLJO-UHFFFAOYSA-N manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims 1
- 229910052748 manganese Inorganic materials 0.000 claims 1
- 239000011572 manganese Substances 0.000 claims 1
- 229910001437 manganese ion Inorganic materials 0.000 claims 1
- 229920001993 poloxamer 188 Polymers 0.000 claims 1
- 229910052710 silicon Inorganic materials 0.000 claims 1
- 239000010703 silicon Substances 0.000 claims 1
- 239000011573 trace mineral Substances 0.000 claims 1
- 235000013619 trace mineral Nutrition 0.000 claims 1
Claims (15)
1. Способ получения рекомбинантного фактора VIII из клеток млекопитающих, отличающийся тем, что упомянутые клетки-хозяева млекопитающих, содержащие ген, кодирующий фактор VIII, культивируют в среде с добавлением полиолов, не содержащей белка человека или млекопитающих.
2. Способ по п. 1, отличающийся тем, что среда содержит ионы меди.
3. Способ по п. 1, отличающийся тем, что полиолом является плюроник F-68, который присутствует в среде в концентрации, изменяющейся от примерно 0,025 до примерно 0,2 вес.%.
4. Способ по п. 1, отличающийся тем, что среда содержит сульфат меди в количестве, изменяющемся от примерно 50 до примерно 800 нМ.
5. Способ по п. 2, отличающийся тем, что присутствуют ионы марганца в количестве, изменяющемся от примерно 1,5 до примерно 4,5 нМ.
6. Способ по п. 2, отличающийся тем, что ионы, содержащие молибден, присутствуют в количестве, изменяющемся от примерно 1,5 до примерно 4,5 нМ.
7. Способ по п. 2, отличающийся тем, что ионы, содержащие кремний, присутствуют в количестве, изменяющемся от примерно 75 до примерно 300 нМ.
8. Способ по п. 2, отличающийся тем, что присутствуют ионы хрома в количестве, изменяющемся от примерно 1,0 до примерно 4,0 нМ.
9. Способ по п. 2, отличающийся тем, что присутствуют ионы лития в количестве, изменяющемся от примерно 120 до примерно 480 нМ.
10. Способ по п. 1, отличающийся тем, что упомянутая клетка-хозяин млекопитающего выбирается из группы, состоящей из клеток почки новорожденного хомяка, человеческих эмбриональных клеток почки и клеток яичника китайского хомяка.
11. Рекомбинантный фактор VIII, полученный в соответствии со способом по п. 1, не содержащий белка человека или млекопитающих.
12. Среда для культивирования клеток, не содержащая белка человека или млекопитающих, предназначенная для получения рекомбинантного фактора VIII, содержащая базальную среду, в состав которой входит полиол.
13. Среда по п. 12, содержащая ионы меди.
14. Среда по п. 13, содержащая, по меньшей мере, один микроэлемент, выбранный из группы, состоящей из марганца, молибдена, хрома и лития.
15. Среда по п. 14, содержащая инсулин.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/844,714 US5804420A (en) | 1997-04-18 | 1997-04-18 | Preparation of recombinant Factor VIII in a protein free medium |
US08/844,714 | 1997-04-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU98107565A true RU98107565A (ru) | 2000-02-20 |
RU2222547C2 RU2222547C2 (ru) | 2004-01-27 |
Family
ID=25293446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU98107565/13A RU2222547C2 (ru) | 1997-04-18 | 1998-04-17 | Получение рекомбинантного фактора viii в среде, не содержащей белка |
Country Status (29)
Country | Link |
---|---|
US (2) | US5804420A (ru) |
EP (1) | EP0872487B1 (ru) |
JP (1) | JP4257685B2 (ru) |
KR (1) | KR100496111B1 (ru) |
CN (1) | CN1127518C (ru) |
AR (1) | AR012451A1 (ru) |
AT (1) | ATE342921T1 (ru) |
AU (1) | AU748731B2 (ru) |
BR (1) | BRPI9801092B8 (ru) |
CA (1) | CA2234215C (ru) |
CO (1) | CO4790112A1 (ru) |
CZ (1) | CZ295049B6 (ru) |
DE (1) | DE69836164T2 (ru) |
DK (1) | DK0872487T3 (ru) |
ES (1) | ES2273380T3 (ru) |
HK (1) | HK1018797A1 (ru) |
HU (1) | HU224306B1 (ru) |
ID (1) | ID20193A (ru) |
IL (1) | IL124123A (ru) |
MY (1) | MY115583A (ru) |
NZ (1) | NZ330183A (ru) |
PL (1) | PL192072B1 (ru) |
PT (1) | PT872487E (ru) |
RU (1) | RU2222547C2 (ru) |
SK (1) | SK285684B6 (ru) |
TR (1) | TR199800493A1 (ru) |
TW (1) | TW490469B (ru) |
UA (1) | UA66340C2 (ru) |
ZA (1) | ZA983234B (ru) |
Families Citing this family (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9501040D0 (en) * | 1995-01-19 | 1995-03-08 | Quadrant Holdings Cambridge | Dried composition |
US8183344B2 (en) * | 1996-04-24 | 2012-05-22 | University Of Michigan | Inactivation resistant factor VIII |
US6475725B1 (en) * | 1997-06-20 | 2002-11-05 | Baxter Aktiengesellschaft | Recombinant cell clones having increased stability and methods of making and using the same |
US6528286B1 (en) * | 1998-05-29 | 2003-03-04 | Genentech, Inc. | Mammalian cell culture process for producing glycoproteins |
AUPP521298A0 (en) * | 1998-08-12 | 1998-09-03 | Life Therapeutics Limited | Purification of fibrinogen |
US6358703B1 (en) * | 1998-12-10 | 2002-03-19 | Bayer Corporation | Expression system for factor VIII |
US20050224355A1 (en) * | 1999-12-23 | 2005-10-13 | Brendon Conlan | Removal of biological contaminants |
AUPP790698A0 (en) * | 1998-12-23 | 1999-01-28 | Life Therapeutics Limited | Separation of microorganisms |
AUPP790898A0 (en) | 1998-12-23 | 1999-01-28 | Life Therapeutics Limited | Renal dialysis |
AUPP971399A0 (en) | 1999-04-12 | 1999-05-06 | Life Therapeutics Limited | Separation of plasma components |
AT409379B (de) | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
AU780415B2 (en) * | 1999-07-13 | 2005-03-17 | Biovitrum Ab | Stable Factor VIII compositions |
US6767741B1 (en) * | 1999-08-27 | 2004-07-27 | Invitrogen Corporation | Metal binding compounds and their use in cell culture medium compositions |
WO2001015789A2 (en) | 1999-08-31 | 2001-03-08 | Sony Computer Entertainment Inc. | Entertainment system, entertainment apparatus, recording medium, and program |
US7077942B1 (en) * | 1999-12-23 | 2006-07-18 | Gradipore Limited | Removal of biological contaminants |
AUPQ691400A0 (en) * | 2000-04-14 | 2000-05-11 | Life Therapeutics Limited | Separation of micromolecules |
AUPQ697300A0 (en) * | 2000-04-18 | 2000-05-11 | Life Therapeutics Limited | Separation apparatus |
WO2001078877A1 (en) | 2000-04-18 | 2001-10-25 | Gradipore Limited | Electrophoresis separation and treatment of samples |
US6923896B2 (en) * | 2000-09-22 | 2005-08-02 | The Texas A&M University System | Electrophoresis apparatus and method |
US20030019753A1 (en) * | 2000-10-05 | 2003-01-30 | David Ogle | Multi-port separation apparatus and method |
AUPR222300A0 (en) * | 2000-12-21 | 2001-01-25 | Life Therapeutics Limited | Electrophoresis device and method |
WO2003013244A1 (en) | 2001-08-03 | 2003-02-20 | The Government Of The United State Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Oral treatment of hemophilia |
EP2292273A3 (en) | 2001-10-10 | 2011-11-23 | BioGeneriX AG | Remodeling and glycoconjugation of peptides |
KR20040065278A (ko) * | 2001-12-21 | 2004-07-21 | 노보 노르디스크 에이/에스 | 변경된 인자 ⅶ 폴리펩티드의 액체 조성물 |
IL162239A0 (en) * | 2001-12-21 | 2005-11-20 | Novo Nordisk Healthcare Ag | Liquid composition of factor vii polypeptides |
US20040009918A1 (en) * | 2002-05-03 | 2004-01-15 | Hanne Nedergaard | Stabilised solid compositions of modified factor VII |
EP2283856B1 (en) | 2002-06-21 | 2017-09-20 | Novo Nordisk Health Care AG | Stabilised solid compositions of factor VIIa polypeptides |
CN101058800B (zh) | 2002-07-09 | 2013-03-13 | 巴克斯特国际有限公司 | 用于细胞培养的无动物蛋白质培养基 |
CN102139114A (zh) * | 2003-02-26 | 2011-08-03 | 尼克塔治疗公司 | 聚合物-因子viii部分缀合物 |
MXPA05009914A (es) * | 2003-03-18 | 2006-01-09 | Novo Nordisk Healthcare Ag | Composiciones farmaceuticas acuosas, liquidas de polipeptidos del factor vii. |
US7897734B2 (en) * | 2003-03-26 | 2011-03-01 | Novo Nordisk Healthcare Ag | Method for the production of proteins |
CA2525224A1 (en) * | 2003-05-23 | 2004-12-02 | Michael Bech Jensen | Protein stabilization in solution |
ATE547114T1 (de) * | 2003-06-25 | 2012-03-15 | Novo Nordisk Healthcare Ag | Flüssige zusammensetzungen von factor vii polypeptiden |
ES2335994T3 (es) * | 2003-07-01 | 2010-04-07 | Novo Nordisk Health Care Ag | Composicion farmaceutica liquida, acuosa de polipeptidos factor vii. |
ES2574581T3 (es) | 2003-08-14 | 2016-06-20 | Novo Nordisk Health Care Ag | Composición farmacéutica líquida acuosa de polipéptidos de tipo Factor VII |
EP2298287B1 (en) * | 2003-12-19 | 2018-04-11 | Novo Nordisk Health Care AG | Stabilised compositions of factor VII polypeptides |
GB0414825D0 (en) | 2004-07-02 | 2004-08-04 | Biostatus Ltd | Gel formulations and uses thereof |
US7422875B2 (en) | 2004-07-20 | 2008-09-09 | Board Of Regents Of The University Of Nebraska | Compositions and methods for increasing protein production |
EP1812557A4 (en) * | 2004-10-29 | 2009-11-04 | Centocor Ortho Biotech Inc | COMPOSITIONS OF CHEMICALLY DEFINED MEDIA |
US20060094104A1 (en) | 2004-10-29 | 2006-05-04 | Leopold Grillberger | Animal protein-free media for cultivation of cells |
RU2442822C2 (ru) * | 2005-01-25 | 2012-02-20 | Вайет Рисерч Айрлэнд Лимитед | Вещества, защищающие клетки от рассечения при сборе микрофильтрацией |
EP1707634A1 (en) * | 2005-03-29 | 2006-10-04 | Octapharma AG | Method for isolation of recombinantly produced proteins |
KR101423344B1 (ko) * | 2006-01-04 | 2014-07-30 | 백스터 인터내셔널 인코포레이티드 | 올리고펩티드-무함유 세포 배양 배지를 이용하여 단백질을 발현시키는 방법 |
WO2008005847A2 (en) * | 2006-06-30 | 2008-01-10 | The Regents Of The University Of Michigan | Method of producing factor viii proteins by recombinant methods |
US20090203077A1 (en) * | 2006-06-30 | 2009-08-13 | The Regents Of The University Of Michigan | Method of producing factor viii proteins by recombinant methods |
AU2007347505B2 (en) | 2007-02-23 | 2012-11-22 | Sk Bioscience Co., Ltd. | Process for producing and purifying factor VIII and its derivatives |
JP5401446B2 (ja) | 2007-04-26 | 2014-01-29 | バイエル ヘルスケア エルエルシー | 凍結貯蔵を目的とした、組み換えタンパク質溶液の安定化 |
CA2703948A1 (en) * | 2007-11-01 | 2009-05-07 | University Of Rochester | Recombinant factor viii having increased stability |
PT2235197T (pt) * | 2007-12-27 | 2017-10-11 | Baxalta Inc | Processos para cultura de células |
DE102008051574A1 (de) | 2008-10-14 | 2010-04-15 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zur Herstellung von Interferon-beta und deren Varianten |
HUE026210T2 (en) * | 2008-11-12 | 2016-05-30 | Baxalta Inc | Procedure for serum-free, insulin-free VII. factor |
BR122021005965B1 (pt) | 2009-07-31 | 2022-01-25 | Baxalta Incorporated | Método para produzir uma composição de desintegrina e metaloproteinase com motivo trombospondina (adamts) |
US8623352B2 (en) | 2009-09-21 | 2014-01-07 | Baxter International Inc. | Stabilized liquid and lyophilized ADAMTS13 formulations |
PL2499165T3 (pl) | 2009-11-13 | 2017-04-28 | Grifols Therapeutics Inc. | Preparaty zawierające czynnik von willenbranda (vwf) oraz sposoby, zestawy i zastosowania z nim powiązane |
PL2563904T3 (pl) | 2010-04-26 | 2015-06-30 | Novartis Ag | Udoskonalona pożywka do hodowli komórkowej |
IL286298B (en) | 2010-07-08 | 2022-08-01 | Baxalta Inc | A method to generate high molecular weight substituted vwf in cell culture |
GB201014121D0 (en) * | 2010-08-24 | 2010-10-06 | Univ Gent | Particulate biologic drug delivery system |
US9062106B2 (en) | 2011-04-27 | 2015-06-23 | Abbvie Inc. | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
EP2702143B1 (en) * | 2011-04-29 | 2018-06-06 | Biocon Research Limited | Methods for reducing accumulation of lactate during culturing and method for producing polypeptide |
RU2600886C2 (ru) | 2011-05-13 | 2016-10-27 | Октафарма Аг | Способ повышения продуктивности эукариотических клеток в продуцировании рекомбинантного fviii |
WO2013098676A1 (en) | 2011-12-30 | 2013-07-04 | Grifols, S.A. | Method for purifying factor viii |
US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
WO2013158279A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Protein purification methods to reduce acidic species |
WO2013158273A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Methods to modulate c-terminal lysine variant distribution |
US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
AU2013381687A1 (en) | 2013-03-12 | 2015-09-24 | Abbvie Inc. | Human antibodies that bind human TNF-alpha and methods of preparing the same |
WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
US8956830B2 (en) | 2013-03-14 | 2015-02-17 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
US9217168B2 (en) | 2013-03-14 | 2015-12-22 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
US20140271622A1 (en) * | 2013-03-14 | 2014-09-18 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
US9677105B2 (en) | 2013-03-14 | 2017-06-13 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
WO2015051293A2 (en) | 2013-10-04 | 2015-04-09 | Abbvie, Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
KR20160138477A (ko) * | 2014-03-23 | 2016-12-05 | 어드밴텍 바이오사이언스 파마큐티카 엘티디에이 | 구리를 이용한 재조합 단백질의 발현 증가 방법 |
EP3778702B1 (en) | 2014-03-25 | 2023-06-28 | F. Hoffmann-La Roche AG | Methods of preparing a poloxamer for use in cell culture medium |
CN106456720A (zh) | 2014-04-01 | 2017-02-22 | 爱德技术生物科学有限公司 | 在无钙作为赋形剂下因子viii的稳定性 |
WO2015149143A2 (en) | 2014-04-01 | 2015-10-08 | Advantech Bioscience Farmacêutica Ltda. | Stable factor viii formulations with low sugar-glycine |
WO2017195745A1 (ja) * | 2016-05-09 | 2017-11-16 | 国立研究開発法人医薬基盤・健康・栄養研究所 | 培地、アルブミン非含有培地用添加剤および多能性幹細胞の培養方法 |
WO2018210771A1 (en) * | 2017-05-17 | 2018-11-22 | Octapharma Ag | Method for the production of a recombinant target protein |
PL3781943T3 (pl) | 2018-04-20 | 2022-08-01 | Janssen Biotech, Inc | Kwalifikacja kolumny chromatograficznej w sposobach produkcji w celu wytwarzania kompozycji przeciwciał anty-il12/il23 |
CN113015805A (zh) | 2018-11-13 | 2021-06-22 | 詹森生物科技公司 | 抗cd38抗体产生期间的痕量金属的控制 |
KR20210142002A (ko) | 2019-03-14 | 2021-11-23 | 얀센 바이오테크 인코포레이티드 | 항-tnf 항체 조성물을 생성하기 위한 제조 방법 |
KR20210141990A (ko) | 2019-03-14 | 2021-11-23 | 얀센 바이오테크 인코포레이티드 | 항-il12/il23 항체 조성물을 생성하기 위한 제조 방법 |
IL302538A (en) | 2019-12-06 | 2023-07-01 | Regeneron Pharma | Anti-VEGF protein preparations and methods for their production |
WO2021198781A2 (en) | 2020-04-02 | 2021-10-07 | Takeda Pharmaceutical Company Limited | Adamts13 variant, compositions, and uses thereof |
MX2022013812A (es) | 2020-05-08 | 2022-12-15 | Regeneron Pharma | Trampas y mini-trampas de vegf y metodos para el tratamiento de trastornos oculares y cancer. |
CN117916260A (zh) | 2021-07-09 | 2024-04-19 | 詹森生物科技公司 | 用于制备抗il12/il23抗体组合物的制造方法 |
JP2024526315A (ja) | 2021-07-09 | 2024-07-17 | ヤンセン バイオテツク,インコーポレーテツド | 抗tnf抗体組成物を製造するための製造方法 |
WO2023167863A1 (en) | 2022-03-02 | 2023-09-07 | Regeneron Pharmaceuticals, Inc. | Manufacturing process for high titer antibody |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4440679A (en) * | 1980-03-05 | 1984-04-03 | Cutter Laboratories, Inc. | Pasteurized therapeutically active protein compositions |
US4767704A (en) * | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
NO162160C (no) * | 1987-01-09 | 1989-11-15 | Medi Cult As | Serumfritt vekstmedium, samt anvendelse derav. |
US5024947A (en) * | 1987-07-24 | 1991-06-18 | Cetus Corporation | Serum free media for the growth on insect cells and expression of products thereby |
JPH0387173A (ja) * | 1987-09-10 | 1991-04-11 | Teijin Ltd | ヒト活性化天然型ファクター8cの製造方法及びそれに用いる形質転換体 |
US5378612A (en) * | 1990-05-11 | 1995-01-03 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Culture medium for production of recombinant protein |
CA2078721A1 (en) * | 1991-09-24 | 1993-03-25 | Hiroshi Yonemura | Process for preparing human coagulation factor viii protein complex |
AU4751697A (en) * | 1996-10-10 | 1998-05-05 | Douglas Danner | Animal cell culture media comprising plant-derived nutrients |
-
1997
- 1997-04-18 US US08/844,714 patent/US5804420A/en not_active Expired - Lifetime
-
1998
- 1998-02-26 ID IDP980270A patent/ID20193A/id unknown
- 1998-03-18 TR TR1998/00493A patent/TR199800493A1/xx unknown
- 1998-04-03 AT AT98106133T patent/ATE342921T1/de active
- 1998-04-03 ES ES98106133T patent/ES2273380T3/es not_active Expired - Lifetime
- 1998-04-03 CA CA002234215A patent/CA2234215C/en not_active Expired - Lifetime
- 1998-04-03 EP EP98106133A patent/EP0872487B1/en not_active Expired - Lifetime
- 1998-04-03 DK DK98106133T patent/DK0872487T3/da active
- 1998-04-03 DE DE69836164T patent/DE69836164T2/de not_active Expired - Lifetime
- 1998-04-03 PT PT98106133T patent/PT872487E/pt unknown
- 1998-04-13 JP JP11590398A patent/JP4257685B2/ja not_active Expired - Lifetime
- 1998-04-15 NZ NZ330183A patent/NZ330183A/xx not_active IP Right Cessation
- 1998-04-16 CZ CZ19981156A patent/CZ295049B6/cs not_active IP Right Cessation
- 1998-04-16 IL IL124123A patent/IL124123A/en not_active IP Right Cessation
- 1998-04-16 AR ARP980101761A patent/AR012451A1/es active IP Right Grant
- 1998-04-17 MY MYPI98001736A patent/MY115583A/en unknown
- 1998-04-17 UA UA98041965A patent/UA66340C2/ru unknown
- 1998-04-17 CO CO98021300A patent/CO4790112A1/es unknown
- 1998-04-17 BR BRPI9801092-1 patent/BRPI9801092B8/pt not_active IP Right Cessation
- 1998-04-17 RU RU98107565/13A patent/RU2222547C2/ru active
- 1998-04-17 CN CN98114971A patent/CN1127518C/zh not_active Expired - Lifetime
- 1998-04-17 HU HU9800901A patent/HU224306B1/hu active IP Right Grant
- 1998-04-17 ZA ZA983234A patent/ZA983234B/xx unknown
- 1998-04-17 AU AU61982/98A patent/AU748731B2/en not_active Expired
- 1998-04-17 SK SK497-98A patent/SK285684B6/sk not_active IP Right Cessation
- 1998-04-17 PL PL325862A patent/PL192072B1/pl unknown
- 1998-04-18 KR KR10-1998-0013934A patent/KR100496111B1/ko not_active IP Right Cessation
- 1998-07-29 TW TW087105849A patent/TW490469B/zh not_active IP Right Cessation
- 1998-09-04 US US09/146,708 patent/US6171825B1/en not_active Expired - Lifetime
-
1999
- 1999-09-08 HK HK99103899A patent/HK1018797A1/xx not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU98107565A (ru) | Получение рекомбинантного фактора viii в среде, не содержащей белка | |
CO4790112A1 (es) | Preparacion del factor recombinante viii en un medio libre de proteina | |
Brunette | Mechanical stretching increases the number of epithelial cells synthesizing DNA in culture | |
DE3851289D1 (de) | Verfahren zur Züchtung rekombinanter Zellen. | |
KR920702417A (ko) | Tcf-ii의 아미노산 배열을 코드하는 dna를 함유한 플라스미드, 형질전환세포, 및 이것을 사용하여 생리 활성물질을 생산하는 방법 | |
DE68926892D1 (de) | Verfahren zur Herstellung von Zellen, die stabil integrierte fremde DNS mit hoher Kopiezahl enthalten, durch dieses Verfahren hergestellte Zellen und Verwendung dieser Zellen zur Herstellung von durch diese fremde DNS kodierten Polypeptiden | |
KR870009023A (ko) | IL-1α 유도체의 제조방법 | |
Lindblad et al. | Hepatocellular phenotypein Vitrois influenced by biophysical features of the collagenous substratum | |
ATE152124T1 (de) | Wachstumsfaktor aus parenchymalen lebenszellen, dafür kodierendes gen, verfahren zur herstellung dieses faktors und transformanten | |
ATE78055T1 (de) | Verfahren zur herstellung von proteinen und transformierten zellen und dna-konstruktionen zur korrektur von mankos und wirtszellen sowie deren herstellung und verwendung. | |
ATE188736T1 (de) | Endothelin-dna und verwendung davon | |
DE69720026D1 (de) | Verfahren zur herstellung von d-aminosäuren durch direkte gärung | |
BRPI9916095B8 (pt) | célula e linhagem de célula expressando uma proteína heteróloga | |
KR880000590A (ko) | 생물학적 활성 플라스미노겐 활성제의 제조방법 | |
ATE197608T1 (de) | Signalsequenzen für die secretion heterologer proteine von hefe | |
KR900009983A (ko) | Tgf-베타1/베타2 : 새로운 망상 변형 성장인자-베타 | |
KR890005264A (ko) | 인터류킨-2를 생산하는 재조합 진핵 세포, 그의 제조 방법 및 그의 제조용 벡터 및 인터류킨-2의 제조방법 | |
Schaeffer | Proposed usage of animal tissue culture terms (Revised 1978) Usage of vertebrate cell, tissue and organ culture terminology | |
DE3769872D1 (de) | Herstellung von rekombinantem protein. | |
BR8406680A (pt) | Processo para preparacao de um plasmidio,processo para expressao eficiente de proteinas heterologas,para preparacao de um transformante e processo para producao de prorrenina | |
DE69226350D1 (de) | Zellkulturverfahren und medium für das wachstum adhärenter tierzellen | |
DE69431068D1 (de) | Das polypeptid eines membran-proteins mit der funktion zur unterstützung des wachstums von prä-b zellen und sein gen | |
Thompson et al. | Collagen synthesis in the developing chick heart. | |
DE69425809T2 (de) | Methoden zur Herstellung von Protein C | |
DE60232443D1 (de) | Polypeptid-destabiliserendes protein in zellen unter aeroben bedingungen und dieses codierende dna |